Cancidas, Caspofungin Acetate, Caspofungin MSD (caspofungin) is a small molecule pharmaceutical. Caspofungin was first approved as Cancidas on 2001-01-26. It is used to treat aspergillosis, candidemia, and mycoses in the USA. It has been approved in Europe to treat aspergillosis and candidiasis. Cancidas's patent is valid until 2032-12-21 (FDA).
|Trade Name||Cancidas, Caspofungin MSD|
|Indication||aspergillosis, candidemia, candidiasis, mycoses|
|Drug Class||Antifungal antibiotics (undefined group)|